Heavy metal poisoning and cardiovascular disease

Journal of Toxicology

Volumn 2011, Issue , 2011, Pages

  Alissa, Eman M ^a   Ferns, Gordon A ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; CADMIUM; LEAD; MERCURY;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENOTYPE ENVIRONMENT INTERACTION; HEAVY METAL POISONING; HEREDITY; HOMEOSTASIS; HUMAN; METABOLIC DISORDER; MOLECULAR MECHANICS; NONHUMAN; NUTRITIONAL ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALIA;

EID: 81555227899     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2011/870125     Document Type: Review

References (220)

1. AHA (American Heart Association), Heart disease and stroke statistics2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2007 115 5 e69 e171
2. WHO (World Health Organization), Cardiovascular diseases (CVDs). fact sheet no. 317, World Health Organization, 2009
3. CDC (Centers for Disease Control and Prevention), The burden of chronic diseases and their risk factorsnational and state perspectives 2004
4. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J., Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data The Lancet 2006 367 9524 1747 1757 (Pubitemid 43767064)
5. Kraemer H. C., Stice E., Kazdin A., Offord D., Kupfer D., How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors The American Journal of Psychiatry 2001 158 6 848 856 (Pubitemid 32547610)
6. Kannel W. B., Gordon T., Evaluation of cardiovascular risk in the elderly: the Framingham study Bulletin of the New York Academy of Medicine 1978 54 6 573 591 (Pubitemid 9159497)
7. Wenger N. K., Gender, coronary artery disease, and coronary bypass surgery Annals of Internal Medicine 1990 112 8 557 558
8. Marenberg M. E., Risch N., Berkman L. F., Floderus B., De Faire U., Genetic susceptibility to death from coronary heart disease in a study of twins The New England Journal of Medicine 1994 330 15 1041 1046 (Pubitemid 24106561)
9. Kannel W. B., Blood pressure as a cardiovascular risk factor: prevention and treatment Journal of the American Medical Association 1996 275 20 1571 1576 (Pubitemid 26154243)
10. Yudkin J. S., Blauth C., Drury P., Fuller J., Henley J., Lancaster T., Lankester J., Lean M., Pentecost B., Press V., Rothman D., Prevention and management of CVD in patients with diabetes mellitus: an evidence base Diabetic Medicine 1996 13 4 S101 S121 (Pubitemid 26312839)
11. Reaven G. M., Syndrome X: 6 years later Journal of Internal Medicine 1994 236 supplement 736 13 22
12. Grundy S. M., Small LDL, atherogenic dyslipidemia, and the metabolic syndrome Circulation 1997 95 1 1 4 (Pubitemid 27029931)
13. Rimm E. B., Stampfer M. J., Giovannucci E., Ascherio A., Spiegelman D., Colditz G. A., Willett W. C., Body size and fat distribution as predictors of CHD among middle-aged and older US men The American Journal of Epidemiology 1995 141 12 1117 1122
14. Howard G., Wagenknecht L. E., Burke G. L., Diez-Roux A., Evans G. W., McGovern P., Nieto F. J., Tell G. S., Cigarette smoking and progression of atherosclerosis: the atherosclerosis risk in communities (ARIC) study Journal of the American Medical Association 1998 279 2 119 124 (Pubitemid 28068301)
15. Wannamethee S. G., Shaper A. G., Walker M., Changes in physical activity mortality, and incidence of CHD in older men The Lancet 1998 351 9116 1603 1608 (Pubitemid 28252175)
16. Appel L. J., Moore T. J., Obarzanek E., Vollmer W. M., Svetkey L. P., Sacks F. M., Bray G. A., Vogt T. M., Cutler J. A., Windhauser M. M., Lin P. H., Karanja N., Simons-Morton D., McCullough M., Swain J., Steele P., Evans M. A., Miller E. R., Harsha D. W., A clinical trial of the effects of dietary patterns on blood pressure The New England Journal of Medicine 1997 336 16 1117 1124
17. Clarke R., Frost C., Collins R., Appleby P., Peto R., Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies The British Medical Journal 1997 314 7074 112 117 (Pubitemid 27022952)
18. Danesh J., Collins R., Peto R., Lipoprotein (a) and CHD. Meta-analysis of prospective studies Circulation 2000 102 10 1082 1085
19. Blake G. J., Ridker P. M., Novel clinical markers of vascular wall inflammation Circulation Research 2001 89 9 763 771 (Pubitemid 34633846)
20. Beattie J. H., Kwun I. S., Is zinc deficiency a risk factor for atherosclerosis? The British Journal of Nutrition 2004 91 2 177 181 (Pubitemid 38268087)
21. Brenneisen P., Steinbrenner H., Sies H., Selenium, oxidative stress, and health aspects Molecular Aspects of Medicine 2005 26 4-5 268 298
22. Hummel M., Standl E., Schnell O., Chromium in metabolic and cardiovascular disease Hormone and Metabolic Research 2007 39 10 743 751 (Pubitemid 350099824)
23. Uriu-Adams J. Y., Keen C. L., Copper, oxidative stress, and human health Molecular Aspects of Medicine 2005 26 4-5 268 298 (Pubitemid 41225353)
24. Gallagher C. M., Meliker J. R., Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis Environmental Health Perspectives 2010 118 12 1676 1684
25. Navas-Acien A., Guallar E., Silbergeld E. K., Rothenberg S. J., Lead exposure and cardiovascular diseasea systematic review Environmental Health Perspectives 2007 115 3 472 482 (Pubitemid 46554449)
26. Salonen J. T., Seppanen K., Nyyssonen K., Korpela H., Kauhanen J., Kantola M., Tuomilehto J., Esterbauer H., Tatzber F., Salonen R., Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in Eastern Finnish men Circulation 1995 91 3 645 655
27. Wang C. H., Jeng J. S., Yip P. K., Chen C. L., Hsu L. I., Hsueh Y. M., Chiou H. Y., Wu M. M., Chen C. J., Biological gradient between long-term arsenic exposure and carotid atherosclerosis Circulation 2002 105 15 1804 1809
28. Mazumder D. N., Chronic arsenic toxicity and human health The Indian Journal of Medical Research 2008 128 4 436 447
29. Goyer R. A., Lead toxicity: current concerns Environmental Health Perspectives 1993 100 177 187 (Pubitemid 23197096)
30. Nawrot T. S., Staessen J. A., Roels H. A., Munters E., Cuypers A., Richart T., Ruttens A., Smeets K., Clijsters H., Vangronsveld J., Cadmium exposure in the population: from health risks to strategies of prevention BioMetals 2010 23 5 769 782
31. Dez S., Human health effects of methylmercury exposure Reviews of Environmental Contamination and Toxicology 2009 198 111 132
32. Libby P., Changing concepts of atherogenesis Journal of Internal Medicine 2000 247 3 349 358 (Pubitemid 30180037)
33. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L., Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity The New England Journal of Medicine 1989 320 14 915 924 (Pubitemid 19101597)
34. Ross R., Atherosclerosisan inflammatory disease The New England Journal of Medicine 1999 340 115 126
35. Libby P., Current concepts of the pathogenesis of the ACS Circulation 2001 104 3 365 372
36. Fang M. Z., Mar W., Cho M. H., Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells Toxicology 2002 177 2-3 253 265 (Pubitemid 34808708)
37. Fang Y.-Z., Yang S., Wu G., Free radicals, antioxidants, and nutrition Nutrition 2002 18 10 872 879 (Pubitemid 35292261)
38. Pinchuk I., Lichtenberg D., The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments Progress in Lipid Research 2002 41 4 279 314 (Pubitemid 34214734)
39. Hu H., Exposure to metals Primary Care 2000 27 983 996 (Pubitemid 32001607)
40. Ibrahim D., Froberg B., Wolf A., Rusyniak D. E., Heavy metal poisoning: clinical presentations and pathophysiology Clinics in Laboratory Medicine 2006 26 1 67 97
41. IARC (International Agency for Research on Cancer), Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Arsenic and Arsenic Compounds (Group 1) 7 Lyon, France World Health Organization. pp. 100-106, 1987
42. Valko M., Morris H., Cronin M. T., Metals, toxicity and oxidative stress Current Medicinal Chemistry 2005 12 10 1161 1208 (Pubitemid 40655271)
43. ATSDR (Agency for Toxic Substances and Disease Registry), CERCLA Priority List of Hazzardous Substances 2005. http://www.atsdr.cdc.gov/cercla/05list. html/
44. Sainio E. L., Jolanki R., Hakala E., Kanerva L., Metals and arsenic in eye shadows Contact Dermatitis 2000 42 1 5 10 (Pubitemid 30052800)
45. Al-Ashban R. M., Aslam M., Shah A. H., Kohl (surma): a toxic traditional eye cosmetic study in Saudi Arabia Public Health 2004 118 4 292 298 (Pubitemid 38559907)
46. Lekouch N., Sedki A., Nejmeddine A., Gamon S., Lead and traditional Moroccan pharmacopoeia Science of the Total Environment 2001 280 39 43 (Pubitemid 33009457)
47. CDC (Centers for Disease Control and Prevention), Childhood lead poisoning associated with tamarind candy and folk remediesCalifornia, 1999-2000 Morbidity and Mortality Weekly Report 2000 51 684 686
48. Meyer P. A., Brown M. J., Falk H., Global approach to reducing lead exposure and poisoning Mutation Research 2008 659 1-2 166 175
49. Woolf A. D., Woolf N. T., Childhood lead poisoning in 2 families associated with spices used in food preparation Pediatrics 2005 116 2 e314 e318 (Pubitemid 44161454)
50. Britain's Food Standards Agency, Health risks from Zam Zam Water 2007. http://www.food.gov.uk/multimedia/pdfs/enforcement/enfs07041.pdf
51. Chiba M., Masironi R., Toxic and trace elements in tobacco and tobacco smoke Bulletin of the World Health Organization 1992 70 2 269 275
52. Al-Saleh I., Shinwari N., Basile P., Al-Dgaither S., Al-Mutairi M., Exposure to cadmium among sheesha smokers and how do they compare to cigarette smokers Journal of Trace Elements in Experimental Medicine 2000 13 4 381 388
53. Dopp E., Kligerman A., Diaz-Bone R., Organoarsenicals. Uptake, metabolism, and toxicity Metal Ions in Life Sciences 2010 7 231 265
54. Papanikolaou N. C., Hatzidaki E. G., Belivanis S., Tzanakakis G. N., Tsatsakis A. M., Lead toxicity update. A brief review Medical Science Monitor 2005 11 10 RA329 RA336
55. Wittmers L. E. Jr., Aufderheide A. C., Wallgren J., Alich A., Rapp G., Lead in bone. IV. Distribution of lead in the human skeleton Archives of Environmental Health 1988 43 6 381 391 (Pubitemid 19014726)
56. IPCS (International Programme on Chemical Safety), CadmiumEnvironmental Health Criteria 134. World Health Organization, Geneva, Switzerland, 1992, http://www.inchem.org/documents/ehc/ehc/ehc134.htm
57. Menke A., Muntner P., Silbergeld E. K., Platz E. A., Guallar E., Cadmium levels in urine and mortality among U.S. adults Environmental Health Perspectives 2009 117 2 190 196
58. Navas-Acien A., Silbergeld E. K., Sharrett A. R., Calderon-Aranda E., Selvin E., Guallar E., Metals in urine and peripheral arterial disease Environmental Health Perspectives 2005 113 2 164 169 (Pubitemid 40326325)
59. Prozialeck W. C., Edwards J. R., Woods J. M., The vascular endothelium as a target of cadmium toxicity Life Sciences 2006 79 16 1493 1506 (Pubitemid 44301275)
60. WHO (World Health Organization), Environmental Health Criteria 18: Arsenic. World Health Organization, Geneva, Switzerland, pp. 43102, 1981
61. Smith A. H., Lopipero P. A., Bates M. N., Steinmaus C. M., Arsenic epidemiology and drinking water standards Science 2002 296 5576 2145 2146 (Pubitemid 34680277)
62. Smith A. H., Smith M. M. H., Arsenic drinking water regulations in developing countries with extensive exposure Toxicology 2004 198 39 44 (Pubitemid 38609015)
63. Axelson O., Dahlgren E., Jansson C. D., Rehnlund S. O., Arsenic exposure and mortality: a case referent study from a Swedish copper smelter The British Journal of Industrial Medicine 1978 35 1 8 15 (Pubitemid 8355603)
64. Tsai S. M., Wang T. N., Ko Y. C., Mortality for certain diseases in areas with high levels of arsenic in drinking water Archives of Environmental Health 1999 54 3 186 193
65. Chiou H. Y., Huang W. I., Su C. L., Chang S. F., Hsu Y. H., Chen C. J., Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic Stroke 1997 28 9 1717 1723
66. Tseng C. H., Chong C. K., Tseng C. P., Hsueh Y. M., Chiou H. Y., Tseng C. C., Chen C. J., Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan Toxicology Letters 2003 137 1-2 15 21
67. National Research Council, Arsenic in Drinking Water 1999 Washington, DC, USA National Academy Press
68. Zierold K. M., Knobeloch L., Anderson H., Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water The American Journal of Public Health 2004 94 11 1936 1937 (Pubitemid 39434824)
69. Meliker J. R., Wahl R. L., Cameron L. L., Nriagu J. O., Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis Environmental Health 2007 6, article 4
70. Rahman M., Tondel M., Ahmad S. A., Chowdhury I. A., Faruquee M. H., Axelson O., Hypertension and arsenic exposure in Bangladesh Hypertension 1999 33 1 74 78 (Pubitemid 29061844)
71. Tseng C. H., Tai T. Y., Chong C. K., Tseng C. P., Lai M. S., Lin B. J., Chiou H. Y., Hsueh Y. M., Hsu K. H., Chen C. J., Long-term arsenic exporure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan Environmental Health Perspectives 2000 108 9 847 851
72. Yuan Y., Marshall G., Ferreccio C., Steinmaus C., Selvin S., Liaw J., Bates M. N., Smith A. H., Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000 The American Journal of Epidemiology 2007 166 12 1381 1391 (Pubitemid 350209048)
73. Chang C. C., Ho S. C., Tsai S. S., Yang C. Y., Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system Journal of Toxicology and Environmental Health, Part A 2004 67 17 1353 1361
74. Navas-Acien A., Scharrett A. R., Silbergeld E. K., Arsenic and cardiovascular disease: a systemic review of the epidemiologic evidence The American Journal of Epidemiology 2005 162 1027 1049
75. Patlolla A. K., Tchounwou P. B., Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats International Journal of Environmental Research and Public Health 2005 2 1 80 83 (Pubitemid 40965103)
76. Waalkes M. P., Fox D. A., States J. C., Patierno S. R., McCabe M. J., Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation Toxicological Sciences 2000 56 2 255 261 (Pubitemid 30497493)
77. Lee T. C., Ho I. C., Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts Archives of Toxicology 1995 69 7 498 504
78. Lee P. C., Ho I. C., Lee T. C., Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells Toxicological Sciences 2005 85 1 541 550
79. Wu M. M., Chiou H. Y., Ho I. C., Chen C. J., Lee T. C., Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects Environmental Health Perspectives 2003 111 11 1429 1438
80. Hsieh Y. C., Hsieh F. I., Lien L. M., Chou Y. L., Chiou H. Y., Chen C. J., Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan Toxicology and Applied Pharmacology 2008 227 1 1 7
81. Barchowsky A., Klei L. R., Dudek E. J., Swartz H. M., James P. E., Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite Free Radical Biology and Medicine 1999 27 11-12 1405 1412 (Pubitemid 30001503)
82. Simeonova P. P., Hulderman T., Harki D., Luster M. I., Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice Environmental Health Perspectives 2003 111 14 1744 1748 (Pubitemid 37407934)
83. Wu M. M., Chiou H. Y., Wang T. W., Hsueh Y. M., Wang I. H., Chen C. J., Lee T. C., Association of arsenic exposure with increased reactive oxidants and decreased antioxidant capacity in a human population of Northeastern Taiwan Environmental Health Perspectives 2001 109 10 1011 1017
84. Chen Y., Santella R. M., Kibriya M. G., Wang Q., Kappil M., Verret W. J., Graziano J. H., Ahsan H., Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules Environmental Health Perspectives 2007 115 10 1415 1420 (Pubitemid 47618082)
85. Ridker P. M., Hennekens C. H., Roitman-Johnson B., Stampfer M. J., Allen J., Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men The Lancet 1998 351 9096 88 92 (Pubitemid 28026634)
86. Esterbauer H., Schaur R. J., Zollner H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radical Biology and Medicine 1991 11 1 81 128 (Pubitemid 121003917)
87. Rosenfeld M. E., Ross R., Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits Arteriosclerosis 1990 10 5 680 687 (Pubitemid 20273338)
88. Santra A., Maiti A., Das S., Lahiri S., Charkaborty S. K., Mazumder D. N., Hepatic damage caused by chronic arsenic toxicity in experimental animals Journal of ToxicologyClinical Toxicology 2000 38 4 395 405 (Pubitemid 30491103)
89. Rosenberg H. G., Systemic arterial disease and chronic arsenicism in infants Archives of Pathology and Laboratory Medicine 1974 97 6 360 365
90. Chen C. J., Hsu L. I., Wang C. H., Shih W. L., Hsu Y. H., Tseng M. P., Lin Y. C., Chou W. L., Chen C. Y., Lee C. Y., Wang L. H., Cheng Y. C., Chen C. L., Chen S. Y., Wang Y. H., Hsueh Y. M., Chiou H. Y., Wu M. M., Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan Toxicology and Applied Pharmacology 2005 206 2 198 206
91. Hayes J. D., McLellan L. I., Glutathione and glutathione dependent enzymes represent a co-ordinately regulated defence against oxidative stress Free Radical Research 1999 31 4 273 300 (Pubitemid 29452854)
92. Wang Y. H., Wu M. M., Hong C. T., Lien L. M., Hsieh Y. C., Tseng H. P., Chang S. F., Su C. L., Chiou H. Y., Chen C. J., Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan Atherosclerosis 2007 192 2 305 312
93. Simeonova P. P., Luster M. I., Arsenic and atherosclerosis Toxicology and Applied Pharmacology 2004 198 3 444 449 (Pubitemid 38969974)
94. Willerson J. T., Ridker P. M., Inflammation as a cardiovascular risk factor Circulation 2004 109 21, supplement 1 II2 II10 (Pubitemid 38724149)
95. Hsueh Y. M., Lin P., Chen H. W., Shiue H. S., Chung C. J., Tsai C. T., Huang Y. K., Chiou H. Y., Chen C. J., Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension Journal of Toxicology and Environmental Health, Part A 2005 68 17-18 1471 1484 (Pubitemid 41783274)
96. Levander O. A., Baumann C. A., Selenium metabolism. VI. Effect of arsenic on the excretion of selenium in the bile Toxicology and Applied Pharmacology 1966 9 1 106 115
97. Wuyi W., Linsheng Y., Shaofan H., Tan J., Li H., Prevention of endemic arsenism with selenium Current Science 2001 81 9 1215 1218 (Pubitemid 33620255)
98. Lin S. M., Yang M. H., Arsenic, selenium, and zinc in patients with blackfoot disease Biological Trace Element Research 1988 15 213 221
99. Hsueh Y. M., Wu W. L., Huang Y. L., Chiou H. Y., Tseng C. H., Chen C. J., Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure Atherosclerosis 1998 141 2 249 257
100. Chen Y., Factor-Litvak P., Howe G. R., Graziano J. H., Brandt-Rauf P., Parvez F., Van Geen A., Ahsan H., Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study The American Journal of Epidemiology 2007 165 5 541 552 (Pubitemid 46340549)
101. Goering P. L., Aposhian H. V., Mass M. J., Cebrin M., Beck B. D., Waalkes M. P., The enigma of arsenic carcinogenesis: role of metabolism Toxicological Sciences 1999 49 1 5 14 (Pubitemid 29266420)
102. Hackam D. G., Anand S. S., Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence Journal of the American Medical Association 2003 290 7 932 940 (Pubitemid 37430466)
103. Lim U., Cassano P. A., Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 19881994 The American Journal of Epidemiology 2002 156 12 1105 1113 (Pubitemid 35453681)
104. Loffredo C. A., Aposhian H. V., Cebrian M. E., Yamauchi H., Silbergeld E. K., Variability in human metabolism of arsenic Environmental Research 2003 92 2 85 91 (Pubitemid 36875703)
105. Chen C. J., Hsueh Y. M., Lai M. S., Shyu M. P., Chen S. Y., Wu M. M., Kuo T. L., Tai T. Y., Increased prevalence of hypertension and long-term arsenic exposure Hypertension 1995 25 1 53 60
106. Markowitz M., Lead poisoning Pediatrics in Review 2000 21 10 327 335
107. CDC (Centers for Disease Control and Prevention), Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control, October 1991 1991 Atlanta, Ga, USA US Department of Health and Human Services
108. Muntner P., Menke A., DeSalvo K. B., Rabito F. A., Batuman V., Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys Archives of Internal Medicine 2005 165 18 2155 2161 (Pubitemid 41434593)
109. Bhatnagar A., Environmental cardiology: studying mechanistic links between pollution and heart disease Circulation Research 2006 99 7 692 705 (Pubitemid 44498303)
110. Staessen J. A., Bulpitt C. J., Fagard R., Lauwerys R. R., Roels H., Thijs L., Amery A., Hypertension caused by low-level lead exposure: myth or fact? Journal of Cardiovascular Risk 1994 1 1 87 97
111. Schwartz J., Lead, blood pressure, and cardiovascular disease in men Archives of Environmental Health 1995 50 1 31 37
112. Nawrot T. S., Thijs L., Den Hond E. M., Roels H. A., Staessen J. A., An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis Journal of Human Hypertension 2002 16 2 123 131 (Pubitemid 34182922)
113. Revis N. W., Zinsmeister A. R., Bull R., Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion Proceedings of the National Academy of Sciences of the United States of America 1981 78 10 6494 6498 (Pubitemid 12179739)
114. Prentice R. C., Kopp S. J., Cardiotoxicity of lead at various perfusate calcium concentrations: functional and metabolic responses of the perfused rat heart Toxicology and Applied Pharmacology 1985 81 3 491 501 (Pubitemid 16185198)
115. Ding Y., Gonick H. C., Vaziri N. D., Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells The American Journal of Hypertension 2000 13 5 552 555 (Pubitemid 30330720)
116. Fowler B. A., Whittaker M. H., Lipsky M., Wang G., Chen X. Q., Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats: an overview BioMetals 2004 17 5 567 568 (Pubitemid 41214269)
117. Schober S. E., Mirel L. B., Graubard B. I., Brody D. J., Flegal K. M., Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III Mortality Study Environmental Health Perspectives 2006 114 10 1538 1541 (Pubitemid 44509651)
118. Kasperczyk S., Birkner E., Kasperczyk A., Kasperczyk J., Lipids, lipid peroxidation and 7-ketocholesterol in workers exposed to lead Human and Experimental Toxicology 2005 24 6 287 295 (Pubitemid 40942612)
119. Nash D., Magder L., Lustberg M., Sherwin R. W., Rubin R. J., Kaufmann R. B., Silbergeld E. K., Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women Journal of the American Medical Association 2003 289 12 1523 1532 (Pubitemid 37430291)
120. Navas-Acien A., Selvin E., Sharrett A. R., Calderon-Aranda E., Silbergeld E., Guallar E., Lead, cadmium, smoking, and increased risk of peripheral arterial disease Circulation 2004 109 25 3196 3201
121. Lee D. H., Lim J. S., Song K., Boo Y., Jacobs D. R., Graded associations of blood lead and urinary cadmium concentrations with oxidative stress related markers in the U.S. population: results from the third National Health and Nutrition Examination Survey Environmental Health Perspectives 2006 114 3 350 354 (Pubitemid 43338258)
122. Bertel O., Buehler F. R., Ott J., Lead-induced hypertension: blunted beta-adrenoceptor-mediated functions The British Medical Journal 1978 1 6112 551 (Pubitemid 8318922)
123. Jhaveri R. C., Lavorgna L., Dube S. K., Glass L., Khan F., Evans H. E., Relationship of blood pressure to blood lead concentrations in small children Pediatrics 1979 63 4 674 676 (Pubitemid 9125489)
124. Bener A., Obineche E., Gillett M., Pasha M. A. H., Bishawi B., Association between blood levels of lead, blood pressure and risk of diabetes and heart disease in workers International Archives of Occupational and Environmental Health 2001 74 5 375 378 (Pubitemid 32691284)
125. Den Hond E., Nawrot T., Staessen J. A., The relationship between blood pressure and blood lead in NHANES III. National Health and Nutritional Survey Journal of Human Hypertension 2002 16 8 563 568 (Pubitemid 35021363)
126. Rothenberg S. J., Manalo M., Jiang J., Cuellar R., Reyes S., Sanchez M., Diaz M., Khan F., Aguilar A., Reynoso B., Juaregui M., Acosta S., Johnson C., Blood lead level and blood pressure during pregnancy in south central Los Angeles Archives of Environmental Health 1999 54 6 382 389 (Pubitemid 30013667)
127. Vupputuri S., He J., Muntner P., Bazzano L. A., Whelton P. K., Batuman V., Blood lead level is associated with elevated blood pressure in blacks Hypertension 2003 41 3 463 468 (Pubitemid 36314617)
128. Kopp S. J., Barron J. T., Tow J. P., Cardiovascular actions of lead and relationship to hypertension: a review Environmental Health Perspectives 1988 78 91 99
129. Gonick H. C., Ding Y., Bondy S. C., Ni Z., Vaziri N. D., Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species Hypertension 1997 30 6 1487 1492 (Pubitemid 27528093)
130. Ercal N., Gurer-Orhan H., Aykin-Burns N., Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage Current Topics in Medicinal Chemistry 2001 1 6 529 539
131. Vaziri N. D., Lin C. Y., Farmand F., Sindhu R. K., Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension Kidney International 2003 63 1 186 194 (Pubitemid 35463920)
132. Mishra K. P., Singh V. K., Rani R., Yadav V. S., Chandran V., Srivastava S. P., Seth P. K., Effect of lead exposure on the immune response of some occupationally exposed individuals Toxicology 2003 188 2-3 251 259 (Pubitemid 36588903)
133. Vaziri N. D., Ding Y., Ni Z., Gonick H. C., Altered nitric oxide metabolism and increased oxygen free radical activity in lead induced hypertension: effect of lazaroid therapy Kidney International 1997 52 4 1042 1046 (Pubitemid 27435837)
134. Kaji T., Suzuki M., Yamamoto C., Mishima A., Sakamoto M., Kozuka H., Severe damage of cultured vascular endothelial cell monolayer after simultaneous exposure to cadmium and lead Archives of Environmental Contamination and Toxicology 1995 28 2 168 172
135. Fujiwara Y., Kaji T., Yamamoto C., Sakamoto M., Kozuka H., Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells Toxicology 1995 98 105 110
136. Ding Y., Vaziri N. D., Gonick H. C., Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside Environmental Research 1998 76 2 107 113 (Pubitemid 28125590)
137. Vaziri N. D., Liang K., Ding Y., Increased nitric oxide inactivation by reactive oxygen species in lead induced hypertension Kidney International 1999 56 4 1492 1498 (Pubitemid 29451255)
138. Rodrguez-Iturbe B., Sindhu R. K., Quiroz Y., Vaziri N. D., Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF- B activation, and overexpression of tubulointerstitial angiotensin II Antioxidants and Redox Signaling 2005 7 9-10 1269 1274 (Pubitemid 41232524)
139. Bogden J. D., Gertner S. B., Kemp F. W., McLeod R., Bruening K. S., Chung H. R., Dietary lead and calcium: effects on blood pressure and renal neoplasia in Wistar rats Journal of Nutrition 1991 121 5 718 728
140. Goldstein G. W., Evidence that lead acts as a calcium substitute in second messenger metabolism 14 Proceedings of the 9th International Neurotoxicology Conference; October 1991 1993 Little Rock, Ark, USA 97 101 Neurotoxicology
141. Simons T. J. B., Lead-calcium interactions in cellular lead toxicity 14 Proceedings of the 9th International Neurotoxicology Conference; October 1991 1996 Little Rock, Ark, USA 77 86 Neurotoxicology (Pubitemid 23292793)
142. Duchen M. R., Mitochondria and Ca 2+ in cell physiology and pathophysiology Cell Calcium 2000 28 5-6 339 348
143. Chai S., Webb R. C., Effects of lead on vascular reactivity Environmental Health Perspectives 1988 78 85 89
144. Ruff H. A., Markowitz M. E., Bijur P. E., Rosen J. F., Relationships among blood lead levels, iron deficiency, and cognitive development in two-year old children Environmental Health Perspectives 1996 104 2 180 185 (Pubitemid 26092621)
145. Miller G. D., Massaro T. F., Massaro E. J., Interactions between lead and essential elements: a review NeuroToxicology 1990 11 1 99 120 (Pubitemid 20204085)
146. Ahamed M., Singh S., Behari J. R., Kumar A., Siddiqui M. K. J., Interaction of lead with some essential trace metals in the blood of anemic children from Lucknow, India Clinica Chimica Acta 2007 377 1-2 92 97 (Pubitemid 44908235)
147. Claudio L., Lee T., Wolff M. S., Wetmur J. G., A murine model of genetic susceptibility to lead bioaccumulation Fundamental and Applied Toxicology 1997 35 1 84 90
148. Goering P. L., Lead-protein interactions as a basis for lead toxicity NeuroToxicology 1993 14 2-3 45 60 (Pubitemid 23292790)
149. Sithisarankul P., Schwartz B. S., Lee B. K., Strickland P. T., Urinary 5-aminolevulinic acid (ALA) adjusted by creatinine: a surrogate for plasma ALA? Journal of Occupational and Environmental Medicine 1998 40 10 901 906 (Pubitemid 28493490)
150. Pounds J. G., Effect of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review NeuroToxicology 1984 5 3 295 331
151. Fullmer C. S., Intestinal calcium and lead absorption: effects of dietary lead and calcium Environmental Research 1991 54 2 159 169
152. Fullmer C. S., Lead-calcium interactions: involvement of 1,25-dihydroxyvitamin D Environmental Research 1997 72 1 45 55 (Pubitemid 27053557)
153. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Ellis M. C., Fullan A., Hinton L. M., Jones N. L., Kimmel B. E., Kronmal G. S., Lauer P., Lee V. K., Loeb D. B., Mapa F. A., McClelland E., Meyer N. C., Mintier G. A., Moeller N., Moore T., Morikang E., Prass C. E., Quintana L., Starnes S. M., Schatzman R. C., Brunke K. J., Drayna D. T., Risch N. J., Bacon B. R., Wolff R. K., A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nature Genetics 1996 13 4 399 408 (Pubitemid 26256612)
154. Roy C. N., Penny D. M., Feder J. N., Enns C. A., The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells Journal of Biological Chemistry 1999 274 13 9022 9028 (Pubitemid 29164707)
155. Zoller H., Pietrangelo A., Vogel W., Weiss G., Duodenal metal transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis The Lancet 1999 353 9170 2120 2123 (Pubitemid 29278482)
156. ATSDR (Agency for Toxic Substances and Disease Registry), Public Health Statement for Cadmium 2008. http://www.atsdr.cdc.gov/phs/phs.asp?id=46tid=15
157. EC (European Commission), Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE). Opinion on the results of the risk assessment of: cadmium metal human health (CAS-No.: 7440-43-9 EINECS-no.: 231-152-8), cadmium oxide human health (CAS-No.: 1306-19-0 EINECS-no.: 215-146-2). C7/VR/csteeop/Cdmet-ox hh/080104 D(04), 2004, http://ec.europa.eu/health/phrisk/ committees/sct/documents/out220en.pdf
158. CONTAM, Scientific opinion of the panel on contaminants in the food chain
159. Edwards J. R., Prozialeck W. C., Cadmium, diabetes and chronic kidney disease Toxicology and Applied Pharmacology 2009 238 3 289 293
160. Bernhard D., Rossmann A., Henderson B., Kind M., Seubert A., Wick G., Increased serum cadmium and strontium levels in young smokers: effects on arterial endothelial cell gene transcription Arteriosclerosis, Thrombosis and Vascular Biology 2006 26 4 833 838 (Pubitemid 43732159)
161. Tellez-Plaza M., Navas-Acien A., Crainiceanu C. M., Guallar E., Cadmium exposure and hypertension in the 19992004 National Health and Nutrition Examination Survey (NHANES) Environmental Health Perspectives 2008 116 1 51 56
162. Sarkar S., Yadav P., Trivedi R., Bansal A. K., Bhatnagar D., Cadmium-induced lipid peroxidation and the status of the antioxidant system in rat tissues Journal of Trace Elements in Medicine and Biology 1995 9 3 144 149
163. Satarug S., Nishijo M., Lasker J. M., Edwards R. J., Moore M. R., Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases? Tohoku Journal of Experimental Medicine 2006 208 3 179 202
164. Staessen J. A., Kuznetsova T., Roels H. A., Emelianov D., Fagard R., Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Public Health and Environmental Exposure to Cadmium Study Group The American Journal of Hypertension 2000 13 2 146 156 (Pubitemid 30125637)
165. Nawrot T., Den Hond E., Thijs L., Staessen J. A., Isolated systolic hypertension and the risk of vascular disease Current Hypertension Reports 2003 5 5 372 379 (Pubitemid 38898960)
166. Whittemore A. S., DiCiccio Y., Provenzano G., Urinary cadmium and blood pressure: results from the NHANES II Survey Environmental Health Perspectives 1991 91 133 140
167. Haswell-Elkins M., Satarug S., O'Rourke P., Moore M., Ng J., McGrath V., Walmby M., Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes Environmental Research 2008 106 3 379 383 (Pubitemid 351296206)
168. Schwartz G. G., Il'Yasova D., Ivanova A., Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III Diabetes Care 2003 26 2 468 470 (Pubitemid 36929075)
169. Houtman J. P., Prolonged low-level cadmium intake and atherosclerosis Science of the Total Environment 1993 138 13 31 36
170. Everett C. J., Frithsen I. L., Association of urinary cadmium and myocardial infarction Environmental Research 2008 106 2 284 286 (Pubitemid 351162984)
171. Messner B., Knoflach M., Seubert A., Ritsch A., Pfaller K., Henderson B., Shen Y. H., Zeller I., Willeit J., Laufer G., Wick G., Kiechl S., Bernhard D., Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance Arteriosclerosis, Thrombosis and Vascular Biology 2009 29 9 1392 1398
172. Schutte R., Nawrot T., Richart T., Thijs L., Roels H. A., Van Bortel L. M., Struijker-Boudier H., Staessen J. A., Arterial structure and function and environmental exposure to cadmium Occupational and Environmental Medicine 2008 65 6 412 419 (Pubitemid 351775802)
173. Varoni M. V., Palomba D., Gianorso S., Anania V., Cadmium as an environmental factor of hypertension in animals: new perspectives on mechanisms Veterinary Research Communications 2003 27 supplement 1 807 810 (Pubitemid 37121455)
174. Martynowicz H., Skoczyska A., Wojakowska A., Turczyn B., Serum vasoactive agents in rats poisoned with cadmium International Journal of Occupational Medicine and Environmental Health 2004 17 4 479 485 (Pubitemid 40223112)
175. Yiin S. J., Chern C. L., Sheu J. Y., Tseng W. C., Lin T. H., Cadmium induced renal lipid peroxidation in rats and protection by selenium Journal of Toxicology and Environmental Health, Part A 1999 57 6 403 413
176. Wolf M. B., Baynes J. W., Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction BioMetals 2007 20 1 73 81 (Pubitemid 46292031)
177. Abu-Hayyeh S., Sian M., Jones K. G., Manuel A., Powell J. T., Cadmium accumulation in aortas of smokers Arteriosclerosis, Thrombosis and Vascular Biology 2001 21 5 863 867 (Pubitemid 32448781)
178. Kyselovic J., Martinka P., Batova Z., Gazova A., Godfraind T., Calcium channel blocker inhibits western-type diet-evoked atherosclerosis development in apoE-deficient mice Journal of Pharmacology and Experimental Therapeutics 2005 315 1 320 328 (Pubitemid 41380527)
179. Simovich M. J., Conrad M. E., Umbreit J. N., Moore E. G., Hainsworth L. N., Smith H. K., Cellular location of proteins related to iron absorption and transport The American Journal of Hematology 2002 69 3 164 170 (Pubitemid 34177469)
180. Steffensen I. L., Mesna O. J., Andruchow E., Namork E., Hylland K., Andersen R. A., Cytotoxicity and accumulation of Hg, Ag, Cd, Cu, Pb and Zn in human peripheral T and B lymphocytes and monocytes in vitro General Pharmacology 1994 25 8 1621 1633
181. Prozialeck W. C., Edwards J. R., Nebert D. W., Woods J. M., Barchowsky A., Atchison W. D., The vascular system as a target of metal toxicity Toxicological Sciences 2008 102 2 207 218 (Pubitemid 351404893)
182. Flanagan P. R., McLellan J. S., Haist J., Increased dietary cadmium absorption in mice and human subjects with iron deficiency Gastroenterology 1978 74 5 841 846 (Pubitemid 8332337)
183. El Heni J., Messaoudi I., Hammouda F., Kerkeni A., Protective effects of selenium (Se) and zinc (Zn) on cadmium (Cd) toxicity in the liver of the rat: effects on the oxidative stress Ecotoxicology and Environmental Safety 2009 72 5 1559 1564
184. Margoshes M., Vallee B. L., A cadmium protein from equine kidney cortex Journal of the American Chemical Society 1957 79 17 4813 4814
185. Kaji T., Mishima A., Koyanagi E., Yamamoto C., Sakamoto M., Kozuka H., Possible mechanism for zinc protection against cadmium cytotoxicity in cultured vascular endothelial cells Toxicology 1992 76 3 257 270 (Pubitemid 23011046)
186. Andrews G. K., Regulation of metallothionein gene expression by oxidative stress and metal ions Biochemical Pharmacology 2000 59 1 95 104
187. Young J. C., Agashe V. R., Siegers K., Hartl F. U., Pathways of chaperone-mediated protein folding in the cytosol Nature Reviews Molecular Cell Biology 2004 5 10 781 791 (Pubitemid 39336272)
188. Jeong E. M., Moon C. H., Kim C. S., Cadmium stimulates the expression of ICAM-1 via NF-kappaB activation in cerebrovascular endothelial cells Biochemical and Biophysical Research Communications 2004 320 887 892
189. Waisberg M., Joseph P., Hale B., Beyersmann D., Molecular and cellular mechanisms of cadmium carcinogenesis Toxicology 2003 192 2-3 95 117 (Pubitemid 37311405)
190. Ikediobi C. O., Badisa V. L., Ayuk-Takem L. T., Latinwo L. M., West J., Response of antioxidant enzymes and redox metabolites to cadmium-induced oxidative stress in CRL-1439 normal rat liver cells International Journal of Molecular Medicine 2004 14 1 87 92
191. Yano C. L., Marcondes M. C., Cadmium chloride-induced oxidative stress in skeletal muscle cells in vitro Free Radical Biology and Medicine 2005 39 10 1378 1384 (Pubitemid 41540092)
192. US EPA (US Environmental Protection Agency), Mercury study report to Congress vol. 7 1997 Washington, DC, USA Environmental Protection Agency
193. Salonen J. T., Seppnen K., Lakka T. A., Salonen R., Kaplan G. A., Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland Atherosclerosis 2000 148 2 265 273 (Pubitemid 30064457)
194. Lund B. O., Miller D. M., Woods J. S., Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria Biochemical Pharmacology 1993 45 10 2017 2024 (Pubitemid 23162597)
195. Huang Y. L., Cheng S. L., Lin T. H., Lipid peroxidation in rats administrated with mercuric chloride Biological Trace Element Research 1996 52 2 193 206 (Pubitemid 26182194)
196. Rissanen T., Voutilainen S., Nyyssonen K., Lakka T. A., Salonen J. T., Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study Circulation 2000 102 22 2677 2679
197. Virtanen J. K., Voutilainen S., Rissanen T. H., Mursu J., Tuomainen T. P., Korhonen M. J., Valkonen V. P., Seppnen K., Laukkanen J. A., Salonen J. T., Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in Eastern Finland Arteriosclerosis, Thrombosis and Vascular Biology 2005 25 1 228 233 (Pubitemid 40054281)
198. Guallar E., Sanz-Gallardo M. I., van't Veer P., Bode P., Aro A., Gmez-Aracena J., Kark J. D., Riemersma R. A., Martn-Moreno J. M., Kok F. J., Mercury, fish oils, and the risk of myocardial infarction The New England Journal of Medicine 2002 347 22 1747N 1754N
199. Yoshizawa K., Rimm E. B., Morris J. S., Spate V. L., Hsieh C. C., Spiegelman D., Stampfer M. J., Willett W. C., Mercury and the risk of coronary heart disease in men The New England Journal of Medicine 2002 347 22 1755 1760 (Pubitemid 35375614)
200. Hallgren C. G., Hallmans G., Jansson J. H., Marklund S. L., Huhtasaari F., Schtz A., Strmberg U., Vessby B., Skerfving S., Markers of high fish intake are associated with decreased risk of a first myocardial infarction The British Journal of Nutrition 2001 86 3 397 404 (Pubitemid 32916197)
201. Nakagawa R., Concentration of mercury in hair of diseased people in Japan Chemosphere 1995 30 1 135 140
202. Srensen N., Murata K., Budtz-Jrgensen E., Weihe P., Grandjean P., Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age Epidemiology 1999 10 4 370 375 (Pubitemid 29288234)
203. Yonaha M., Saito M., Sagai M., Stimulation of lipid peroxidation by methyl mercury in rats Life Sciences 1983 32 13 1507 1514 (Pubitemid 13118991)
204. Clarkson T. W., The pharmacology of mercury compounds Annual Review of Pharmacology 1972 12 375 406
205. InSug O., Datar S., Koch C. J., Shapiro I. M., Shenker B. J., Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve Toxicology 1997 124 3 211 224 (Pubitemid 28055531)
206. Gatti R., Belletti S., Uggeri J., Vettori M. V., Mutti A., Scandroglio R., Orlandini G., Methylmercury cytotoxicity in PC12 cells is mediated by primary glutathione depletion independent of excess reactive oxygen species generation Toxicology 2004 204 2-3 175 185 (Pubitemid 39244077)
207. Shumilla J. A., Wetterhahn K. E., Barchowsky A., Inhibition of NF- B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism Archives of Biochemistry and Biophysics 1998 349 2 356 362 (Pubitemid 28368681)
208. Kim S. H., Johnson V. J., Sharma R. P., Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and P38 MAPK signaling pathways Nitric Oxide 2002 7 1 67 74 (Pubitemid 35007262)
209. Kumar S. V., Maitra S., Bhattacharya S., In vitro binding of inorganic mercury to the plasma membrane of rat platelet affects Na+-K+-ATPase activity and platelet aggregation BioMetals 2002 15 1 51 57 (Pubitemid 34123789)
210. Sarafian T., Verity M. A., Oxidative mechanisms underlying methyl mercury neurotoxicity International Journal of Developmental Neuroscience 1991 9 2 147 153
211. Leonard A., Jacquet P., Lauwerys R. R., Mutagenicity and teratogenicity of mercury compounds Mutation ResearchReviews in Genetic Toxicology 1983 114 1 1 18 (Pubitemid 13216941)
212. Rowland I. R., Robinsin R. D., Doherty R. A., Effects of diet on mercury metabolism and excretion in mice given methylmercury: role of gut flora Archives of Environmental Health 1984 39 6 401 408 (Pubitemid 15166147)
213. Meltzer H. M., Mundal H. H., Alexander J., Bibow K., Ydersbond T. A., Does dietary arsenic and mercury affect cutaneous bleeding time and blood lipids in humans? Biological Trace Element Research 1994 46 1-2 135 153 (Pubitemid 24381972)
214. Adachi T., Yasutake A., Hirayama K., Influence of dietary protein levels on the fate of methylmercury and glutathione metabolism in mice Toxicology 1992 72 1 17 26
215. Bala K. V. C. S., Sridevi K., Rao K. P., Inhibition of methyl mercury chloride-induced chromosomal damage by -linolenic acid Food and Chemical Toxicology 1993 31 6 431 434 (Pubitemid 23181259)
216. Prasad K. N., Ramanjujam M., Vitamin E and vitamin C alter the effect of methyl mercuric chloride on neuroblastoma and glioma cells in culture Environmental Research 1980 21 343 349 (Pubitemid 10037205)
217. Ganther H. E., Goudie C., Sunde M. L., Kopecky M. J., Wagner P., Sang-Hwan O. H., Hoekstra W. G., Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna Science 1972 175 4026 1122 1124
218. Raymond L. J., Ralston N. V. C., Mercury: selenium interactions and health implications Seychelles Medical and Dental Journal 2004 7 72 77
219. Yoshida M., Watanabe C., Kishimoto M., Yasutake A., Satoh M., Sawada M., Akama Y., Behavioral changes in metallothionein-null mice after the cessation of long-term, low-level exposure to mercury vapor Toxicology Letters 2006 161 3 210 218 (Pubitemid 43138861)
220. Goering P. L., Fisher B. R., Noren B. T., Papaconstantinou A., Rojko J. L., Marler R. J., Mercury induces regional and cell-specific stress protein expression in rat kidney Toxicological Sciences 2000 53 2 447 457 (Pubitemid 30100162)